Neural transplantation in the new millenium

Cell Transplantation

Volumn 11, Issue 6, 2002, Pages 615-618

  Borlongan, C V ^a,b   Sanberg, P R ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CELL TRANSPLANTATION; CELL VIABILITY; HUMAN; LABORATORY; MEDICAL LITERATURE; NERVE CELL; NEUROSCIENCE; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0036412674     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000002783985558     Document Type: Note

References (65)

1. Almawi, W. Y.; Assi, J. W.; Chudzik, D. M.; Jaoude, M. M. A.; Rieder, M. J. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (Tacrolimus)1. Cell Transplant. 10:615-623; 2001.
2. Almawi, W. Y.; Tamim, H. Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: Glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells. Cell Transplant. 10:161-164; 2001.
3. Armstrong, R. J. E.; Svendsen, C. N. Neural stem cells: From cell biology to cell replacement. Cell Transplant. 9:139-152; 2000.
4. Armstrong, R. J. E.; Watts, C.; Svendsen, C. N.; Dunnett, S. B.; Rosser, A. E. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant. 9:55-64; 2000.
5. Bankiewicz, K. S.; Bringas, J.; Pivirotto, P.; Kutzscher, E.; Nagy, D.; Emborg, M. E. Technique for bilateral intracranial implantation of cells in monkeys using an automated delivery system. Cell Transplant. 9:595-607; 2000.
6. Barker, R. A.; Kendall, A. L.; Widner, H.; and the Neural Tissue Xenografting Project. Neural tissue xenotransplantation: What is needed prior to clinical trials in Parkinson's disease? Cell Transplant. 9:235-246; 2000.
7. Baust, J. M.; Vogel, M. J.; Van Buskirk, R.; Baust, J. G. A molecular basis of cryopreservation failure and its modulation to improve cell survival. Cell Transplant. 10:561-571; 2001.
8. Benazzouz, A.; Piallat, B.; Ni, Z. G.; Koudsie, A.; Pollak, P.; Benabid, A. L. Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease. Cell Transplant. 9:215-221; 2000.
9. Berney, T.; Molano, R. D.; Pileggi, A.; Cattan, P.; Vizzardelli, C.; Ricordi, C.; Inverardi, L. Absence of CSF-1-dependent macrophages does not improve function of transplanted islets of Langerhans. Cell Transplant. 10:633-637; 2001.
10. Blakemore, W. F.; Franklin, J. M. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 9:289-294; 2000.
11. Blits, B.; Dijkhuizen, P. A.; Hermens, W. T. J. M. C.; van Esseveldt, L. K. E.; Boer, G. J.; Verhaagen, J. The use of adenoviral vectors and ex vivo transduced neurotransplants: Towards promotion of neuroregeneration. Cell Transplant. 9:169-178; 2000.
12. Boer, G. J. The Network of European CNS Transplantation and Restoration (NECTAR): An introduction on the occasion of its tenth meeting. Cell Transplant. 9:133-138; 2000.
13. Borlongan, C. V.; Su, T.; Wang, Y. Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells. Cell Transplant. 10:53-58; 2001.
14. Brady, J. L.; Yamashita, K.; Lew, A. M. Enhanced survival of grafts genetically endowed with the ability to block CD2 and B7. Cell Transplant. 10:175-181; 2001.
15. Brevig, T.; Meyer, M.; Kristensen, T.; Zimmer, J. Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-gal antibodies and complement is not toxic for the dopaminergic neurons. Cell Transplant. 10:25-30; 2001.
16. Brierley, C. M. H.; Crang, A. J.; Iwashita, Y.; Gilson, J. M.; Scolding, N. J.; Compston, D. A. S.; Blakemore, W. F. Remyelination of demyelinated CNS axons by transplanted human Schwann cells: The deleterious effect of contaminating fibroblasts. Cell Transplant. 10:305-315; 2001.
17. Brundin, P.; Karlsson, J.; Emgård, M.; Schierle, G. S. K.; Hansson, O.; Petersén, Å.; Castilho, R. F. Improving the survival of grafted changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant. 9:179-195; 2000.
18. Cunningham, J.; Oiwa, Y.; Nagy, D.; Podsakoff, G.; Colosi, P.; Bankiewicz, K. S. Distribution of AAA-TK following intracranial convection-enhanced delivery into rats. Cell Transplant. 9:585-594; 2000.
19. Danielsen, E. H.; Cumming, P.; Andersen, F.; Bender, D.; Brevig, T.; Falborg, L.; Gee, A.; Gillings, N. M.; Hansen, S. B.; Hermansen, F.; Johansen, J.; Johansen, T. E.; Dahl-Jørgensen, A.; Jørgensen, H. A.; Meyer, M.; Munk, O.; Pedersen, E. B.; Poulsen, P. H.; Rodell, A. B.; Sakoh, M.; Simonsen, C. Z.; Smith, D. F.; Søorensen, J. C.; Østergard, L.; Zimmer, J.; Gjedde, A.; Møller, A. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: Preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers. Cell Transplant. 9:247-259; 2000.
20. Date, I.; Shingo, T.; Yoshida, H.; Fujiwara, K.; Kobayashi, K.; Ohmoto, T. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study. Cell Transplant. 9:705-709; 2000.
21. Date, I.; Shingo, T.; Yoshida, H.; Fujiwara, K.; Kobayashi, K.; Takeuchi, A.; Ohmoto, T. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant. 10:397-401; 2001.
22. Eaton, M. J.; Martinez, M.; Karmally, S.; Lopez, T.; Sagen, J. Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain. Cell Transplant. 9:637-656; 2000.
23. Emerich, D. F.; Salzberg, H. C. Update on immunoisolation cell therapy for CNS diseases. Cell Transplant. 10:3-24; 2001.
24. Espejo, M.; Cutillas, B.; Arenas, E.; Ambrosio, S. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant. 9:45-53; 2000.
25. Fink, J. S.; Schumacher, J. M.; Ellias, S. L.; Palmer, E. P.; Saint-Hilaire, M.; Shannon, K.; Penn, R.; Starr, P.; VanHorne, C.; Kott, H. S.; Dempsey, P. K.; Fischman, A. J.; Raineri, R.; Manhart, C.; Dinsmore, J.; Isacson, O. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results. Cell Transplant. 9:273-278; 2000.
26. Fujiwara, K.; Date, I.; Shingo, T.; Yoshida, H.; Kobayashi, K.; Takeuchi, A.; Tamiya, T.; Ohmoto, T. Neurotrophic factor-secreting cell grafting for cerebral ischemia: Preliminary report. Cell Transplant. 10:419-422; 2001.
27. Gray, J. A.; Grigoryan, D. V.; Patel, S.; Sinden, J. D.; Hodges, H. Conditionally immortalized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation. Cell Transplant. 9:153-168; 2000.
28. Hamano, K.; Li, T.; Kobayashi, S.; Matsuzaki, M.; Esato, K. Angiogenesis induced by the implantation of self-bone marrow cells: A new material for therapeutic angiogenesis. Cell Transplant. 9:439-443; 2000.
29. Haque, N. S. K.; Isacson, O. Neurotrophic factors NGF and FGF-2 alter levels of huntingtin (IT15) in striatal neuronal cell culture. Cell Transplant. 9:623-627; 2000.
30. Hara, K.; Uchida, K.; Fukunaga, A.; Kuroshima, Y.; Yamada, M.; Kawase, T. Neurite growth capability of rat fetal neuronal cells against matured CNS myelin in vitro. Cell Transplant. 9:717-724; 2000.
31. Howell, L. L.; Byrd, L. D.; McDonough, A. M.; Iuvone, P. M.; Bakay, R. A. E. Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation. Cell Transplant. 9:609-622; 2000.
32. Hurelbrink, C. B.; Armstrong, R. J. E.; Baker, R. A.; Dunnett, S. B.; Rosser, A. E. Hibernated human fetal striatal tissue: Successful transplantation in a rat model of Huntington's disease. Cell Transplant. 9:743-749; 2000.
33. Koopmans, J.; HogenEsch, I.; Copray, S.; Middel, B.; van Dijk, H.; Go, K.-G.; Staal, M. Cryopreservation of porcine fetal ventral mesencephalic tissue for intrastriatal transplantation in Parkinson's disease. Cell Transplant. 10:573-581; 2001.
34. Kosuga, M.; Takahashi, S.; Sasaki, K.; Enosawa, S.; Li, K.; Okuyama, S.; Fujino, M.; Suzuki, S.; Yamada, M.; Matsuo, N.; Sakuragawa, N.; Okuyama, T. Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant. 9:687-692; 2000.
35. Kosuga, M.; Takahashi, S.; Tanabe, A.; Fujino, M.; Li, X.-K.; Suzuki, S.; Yamada, M.; Kakishita, K.; Ono, F.; Sakuragawa, N.; Okuyama, S. Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: Implication for cell-mediated therapy for lysosome storage disorders. Cell Transplant. 10:435-439; 2001.
36. Larsson, L. C.; Anderson, P.; Widner, H.; Korsgren, O. Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion. Cell Transplant. 10:295-304; 2001.
37. Larsson, L. C.; Czech, K. A.; Brundin, P.; Widner, H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: Immune responses and functional effects. Cell Transplant. 9:261-272; 2000.
38. Li, K.; Yang, M.; Lam, A. C.; Yau, F. W.; Yuen, P. M. P. Effects of Flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant. 9:125-131; 2000.
39. Li, Y.; Chen, J.; Chopp, M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplant. 10:31-40; 2001.
40. McKenzie, A. W.; Georgiou, H. M.; Zhan, Y.; Brady, J. L.; Lew, A M. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody. Cell Transplant. 10:183-193; 2001.
41. Mizumoto, H.; Mizumoto, K.; Whiteley, S. J. O.; Shatos, M.; Klassen, H.; Young, M. J. Transplantation of human neural progenitor cells to the vitreous cavity of the Royal College of Surgeons rat. Cell Transplant. 10:223-233; 2001.
42. Mundt-Petersen, U.; Karlsson, J.; Schierle, G. S. K.; Brundin, P. Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival. Cell Transplant. 9:73-78; 2000.
43. Nakamura, K.; Ahmed, M.; Barr, E.; Leiden, J. M.; Kang, U. J. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxphenylalanine decarboxylation in rodent Parkinsonian models. Cell Transplant. 9:567-576; 2000.
44. Petersén, Å.; Hansson, O.; Emgård, M.; Brundin, P. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor. Cell Transplant. 9:577-584; 2000.
45. Plant, G. W.; Harvey, A. R. A new type of biocompatible bridging structure supports axon regrowth after implantation into the lesioned optic tract. Cell Transplant. 9:759-772; 2000.
46. Rivas-Arancibia, S.; Willing, A. E.; Zigova, T.; Rodriguez, A. I.; Cahill, D. W.; Sanberg, P. R. The effects of taurine on hNT neurons transplanted in adult rat stratum. Cell Transplant. 9:751-758; 2000.
47. Rödter, A.; Winkler, C.; Samii, M.; Nikkhah, G. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant. 9:197-214; 2000.
48. a. Sanberg, P. R.; Brundin, P. Cell transplantation and neuroscience. Cell Transplant. 8:3-6; 1999.
49. Sanchez-Ramos, J.; Song, S.; Dailey, M.; Cardoza-Pelaez, F.; Hazzi, C.; Stedeford, T.; Willing, A.; Freeman, T. B.; Saporta, S.; Zigova, T.; Sanberg, P. R.; Snyder, E. Y. The X-gal caution in neural transplantation studies. Cell Transplant. 9:657-667; 2000.
50. Schraermeyer, U.; Thumann, G.; Luther, T.; Kociok, N.; Amhold, S.; Kruttwig, K.; Andressen, C.; Addicks, K.; Bartz-Schmidt, K. U. Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats. Cell Transplant. 10:673-680; 2001.
51. Terada, S.; Matsuura, K.; Enosawa, S.; Miki, M.; Hoshika, A.; Suzuki, S.; Sakuragawa, N. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplant. 9:701-704; 2000.
52. Thorsen, F.; Read, T.; Lund-Johansen, M.; Tysnes, B. B.; Bjerkvig, R. Alginate-encapsulated producer cells: A potential new approach for the treatment of malignant brain tumors. Cell Transplant. 9:773-783; 2000.
53. Tkaczuk, J.; Bes, J. C.; Duplan, H.; Sallerin, B.; Tafani, M.; Charlet, J. P.; Abbal, M.; Lazorthes, Y.; Ohayon, E. Intrathecal grafting of unencapsulated adrenal medullary tissue can bring CD4 T lymphocytes into CSF: A potentially deleterious event for the graft. Cell Transplant. 9:79-91; 2000.
54. Tuszynski, M. H. Proceedings of the meeting of the American Society for Neural Transplantation and Repair (ASNTR), 1999. Cell Transplant. 9:565-566; 2000.
55. Tuszynski, M. H. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant. 9:629-636; 2000.
56. Verdugo, M. E.; Alling, J.; Lazar, E. S.; del Cerro, M.; Ray, J.; Aguirre, G. Posterior segment approach for subretinal transplantation or injection in the canine model. Cell Transplant. 10:317-327; 2001.
57. Vizzardelli, C.; Potter, E. D.; Berney, T.; Pileggi, A.; Inverardi, L.; Ricordi, C.; Sagen, J. Automated method for isolation of adrenal medullary chromaffin cells from neonatal porcine glands. Cell Transplant. 10:689-696; 2001.
58. Watts, C.; Brasted, P. J.; Dunnett, S. B. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces. Cell Transplant. 9:395-407; 2000.
59. Watts, C.; Dunnett, S. B. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant. 9:223-234; 2000.
60. Watts, C.; McNamara, I. R.; Dunnett, S. B. Volume and differentiation of striatal grafts in rats: Relationship to the number of cells implanted. Cell Transplant. 9:65-72; 2000.
61. Weis, C.; Kaufmann, W. A.; Humpel, C. Lipid-mediated in vivo gene transfer replaces the loss of choline acetyltransferase activity after unilateral fimbria-fornix aspiration. Cell Transplant. 10:681-688; 2001.
62. Wenning, G. K.; Tison, F.; Scherfler, C.; Puschban, Z.; Waldner, R.; Granata, R.; Ghorayeb, I.; Poewe, W. Towards neurotransplantation in multiple system atrophy: Clinical rationale, pathophysiological basis, and preliminary experimental evidence. Cell Transplant. 9:279-288; 2000.
63. Yurek, D. M.; Fletcher-Turner, A.; Moore, J.; Chai, L.; Mahanthappa, N. Co-grafts of fetal ventral mesencephalon and fibroblasts expressing sonic hedgehog: Effect on survival and function of dopamine grafts. Cell Transplant. 10:665-671; 2001.
64. Zaman, V.; Turner, D. A.; Sherry, A. K. Prolonged post-lesion transplantation delay adversely influences survival of both homotopic and heterotopic fetal hippocampal cell grafts in kainate-lesioned CA3 region of adult hippocampus. Cell Transplant. 10:41-52; 2001.
65. Zurn, A. D.; Henry, H.; Schluep, M.; Aubert, V.; Winkel, L.; Eilers, B.; Bachmann, C.; Aebischer, P. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell Transplant. 9:471-484; 2000.